Sotyktu

Sotyktu Coupons & Discount Card - Compare Prices Near You

Deucravacitinib, marketed under the brand name Sotyktu, is a prescription medication used to treat moderate to severe plaque psoriasis in adults. This condition is characterized by red, thickened, and scaly patches on the skin. Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor, which works by targeting a specific enzyme in the Janus kinase family that is responsible for causing inflammation in the body. By inhibiting this enzyme, the medication helps to reduce the symptoms of psoriasis. It is taken orally in tablet form once daily. While effective, patients should be aware of potential side effects, including an increased risk of infections, such as upper respiratory infections and herpes simplex. As with all medications, it is important to consult with a healthcare professional to ensure it is safe and appropriate for individual use.
Our Sotyktu coupons are free to use. You can print the coupon, email it to yourself, or receive the Sotyktu coupon via text message. To get your free discount, show the pharmacist your Sotyktu savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Sotyktu prices will update based on your prescription needs. Above our Sotyktu coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Sotyktu savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

6MG, Sotyktu (30 Tablets)

Select pharmacy

Pharmacy logo

Rite Aid

$6791.98

COUPON PRICE
Pharmacy logo

Walgreens

$7079.76

COUPON PRICE

Sotyktu savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$6791.98

BIN

ID

PCN

GRP

019876

LH3E71F48E

CHIPPO

LHX

Powered by

This card is not insurance

Related JAK inhibitors prescriptions

coupons from$8872.15Save 72%
coupons from$5677.91Save 73%
coupons from$2950.57Save 73%
coupons from$7001.37Save 72%
coupons from$2014.14Save 73%
coupons from$2791.28Save 72%

More prescriptions for psoriasis

coupons from$217.11 
coupons from$4.87Save 92%
coupons from$1446.68Save 73%
coupons from$883.1Save 73%
coupons from$508.7Save 73%
coupons from$2893.1Save 72%
coupons from$1307.33Save 73%
coupons from$957.33Save 73%

Related JAK inhibitors prescriptions

Jakafi Save 72%coupons from $8872.15
Cibinqo Save 73%coupons from $5677.91
Xeljanz Save 73%coupons from $2950.57
Rinvoq Save 72%coupons from $7001.37
Opzelura Save 73%coupons from $2014.14
Olumiant Save 72%coupons from $2791.28

More prescriptions for psoriasis

Methoxsalencoupons from $217.11
Clobetasol Save 92%coupons from $4.87
Vtama Save 73%coupons from $1446.68
Zoryve Save 73%coupons from $883.1
Bryhali Save 73%coupons from $508.7
Siliq Save 72%coupons from $2893.1
Enstilar Save 73%coupons from $1307.33
Sernivo Save 73%coupons from $957.33

Sotyktu dosage forms

The average cost for 30 Tablets of Sotyktu at 6MG is $6884.66 with a free coupon. This is 27.95% off the average retail price of $24632.88
DosageQuantityPrice fromPer unit
6MG30 Tablets$6884.66$229.49

Sotyktu Warnings

The following safety information outlines important warnings associated with the use of Sotyktu (deucravacitinib). It is crucial to understand these risks and consult your healthcare provider with any questions or concerns.

  • Severe Allergic Reactions: Although rare, Sotyktu may trigger serious allergic reactions. Seek immediate medical attention if you experience facial or throat swelling, difficulty breathing, or a rash.

  • Serious Infections: This medication may compromise your immune system, increasing your susceptibility to severe infections like tuberculosis, shingles, and hepatitis. You are at greater risk if you have existing or recurring infections, other health conditions that heighten infection risk, live in or travel to regions with high TB rates, or take other immune-suppressing medications.

  • Muscle Damage: Sotyktu can lead to elevated creatine phosphokinase (CPK) levels, indicating potential muscle damage such as rhabdomyolysis. Notify your healthcare provider immediately if you experience unexplained muscle pain, tenderness, weakness, dark urine, fatigue, or fever, as treatment may need to be adjusted.

  • Liver Damage: Elevated liver enzymes can occur with Sotyktu use, signaling possible liver damage. Regular liver function tests will be conducted to monitor your liver health. Report any symptoms like nausea, abdominal pain, or jaundice to your healthcare team promptly.

  • Possible Risk of Cancer: Though extremely rare, some cancer cases, including lymphoma, liver, and breast cancer, have been reported in clinical studies. Discuss your medical history with your psoriasis specialist, especially if you've had cancer before or have concerns about cancer risk.

There are no specific contraindications listed for Sotyktu. Always discuss your medical history and any concerns with your healthcare provider to ensure this medication is suitable for you.

Sotyktu Side Effects

When taking this medication, you may experience some common side effects that are usually mild and manageable. These include upper respiratory infections, mouth ulcers, swollen hair follicles, and acne. Generally, these effects are not severe, but if they persist or worsen, it's advisable to consult with a healthcare provider.

There are more serious side effects that, although rare, require immediate medical attention. These include severe allergic reactions characterized by rash, difficulty breathing, dizziness, and swelling of the face or throat. Additionally, the drug can lower your immune response, making infections more severe or harder to heal, with symptoms such as persistent fever, chills, cough, or non-healing skin sores.

Severe muscle damage, known as rhabdomyolysis, is a potential risk, presenting as dark brown urine, extreme muscle pain, or weakness, accompanied by fever or tiredness. Liver damage is another critical concern, which can manifest through symptoms like persistent nausea, stomach pain, jaundice, or dark urine. Unexplained weight loss, unusual lumps, and signs of kidney problems, such as changes in urination, also warrant immediate medical consultation. In rare cases, this medication may increase the risk of cancer.

If you notice any other unusual effects, contact your healthcare provider for advice. Always remain vigilant and seek medical help promptly if you suspect any severe reactions.

Sotyktu FAQs
Is sotyktu the same as otezla?

Sotyktu and Otezla are not the same. They are both medications used to treat certain conditions, but they have different active ingredients and mechanisms of action. Sotyktu contains the active ingredient deucravacitinib, while Otezla contains apremilast. It is important for patients to follow their healthcare provider's guidance regarding which medication is appropriate for their specific condition.

Sotyktu is expensive due to several factors, including the costs associated with research and development, clinical trials, regulatory approvals, and marketing. Additionally, the pricing may reflect the drug's effectiveness, the complexity of its production, and the lack of generic alternatives. Pharmaceutical companies also consider the potential market size and the need to recoup investments made during the drug's development.

Yes, Sotyktu (deucravacitinib) can weaken the immune system. It is an oral medication used to treat certain autoimmune conditions, and it works by modulating the immune response. As a result, it may increase the risk of infections. It is important for patients to discuss potential risks and benefits with their healthcare provider.

Sotyktu (deucravacitinib) is a medication approved for the treatment of moderate to severe plaque psoriasis in adults. Clinical trials have demonstrated its effectiveness in reducing the severity of psoriasis symptoms. However, individual responses to the medication can vary, and it is important for patients to discuss with their healthcare provider whether Sotyktu is an appropriate treatment option for their specific condition.

Weight loss is not commonly reported as a side effect of Sotyktu (deucravacitinib). If a patient experiences unexpected weight changes while taking this medication, it is advisable to consult with a healthcare provider for further evaluation.